Leg-Reg Briefing March 2019: AMCP Holds Annual Legislative Days; AMCP Comments on Draft Part D Call Letter; FDA Draft Guidance on Naming of Biologics

Leg-Reg Briefing February 2019: Congress Focuses on Pharmaceutical Pricing; States Introduce Bills Affecting Managed Care Pharmacy; Modifying HIPAA Rules to Improve Coordinated Care

Leg-Reg Briefing January 2019: Congress Starts Amid Ongoing Partial Shutdown; Most States Start 2019 Sessions; AMCP to Increase Grassroots Advocacy Efforts

Leg-Reg Briefing September 2018: AMCP Presents at FDA Open Hearing on Biosimilars; AMCP Submits Comments to ASHP; Senate Passes Opioid Package

Leg-Reg Briefing August 2018: CMS Rule on Step Therapy for Part B Medications; Capitol Hill Update; State Legislative Action

Leg-Reg Briefing July 2018: HHS Blueprint to Lower Drug Prices; Capitol Hill Update; AMCP Supports Increased FDA Funding

Leg-Reg Briefing June 2018: Capitol Hill Update: Opioid Legislation; AMCP Action Alerts; FDA Issues Final Guidance on Payer/Manufacturer Communication